164 related articles for article (PubMed ID: 32487733)
1. Novel c-Myc-Targeting Compound
Sriratanasak N; Petsri K; Laobuthee A; Wattanathana W; Vinayanuwattikun C; Luanpitpong S; Chanvorachote P
Mol Pharmacol; 2020 Aug; 98(2):130-142. PubMed ID: 32487733
[TBL] [Abstract][Full Text] [Related]
2. Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.
Losuwannarak N; Roytrakul S; Chanvorachote P
Cancer Genomics Proteomics; 2020; 17(6):781-793. PubMed ID: 33099479
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Protein-Protein Interactions Identifies NECTIN2 as a Target of
Thongsom S; Aksorn N; Petsri K; Roytrakul S; Sriratanasak N; Wattanathana W; Chanvorachote P
Cancer Genomics Proteomics; 2022; 19(5):624-635. PubMed ID: 35985690
[TBL] [Abstract][Full Text] [Related]
4. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C
PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
[TBL] [Abstract][Full Text] [Related]
5. Transport of c-MYC by Kinesin-1 for proteasomal degradation in the cytoplasm.
Lee CM
Biochim Biophys Acta; 2014 Sep; 1843(9):2027-36. PubMed ID: 24821626
[TBL] [Abstract][Full Text] [Related]
6. TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells.
Wu DW; Chen TC; Huang HS; Lee H
Cell Death Dis; 2016 Jun; 7(6):e2290. PubMed ID: 27362807
[TBL] [Abstract][Full Text] [Related]
7. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
[TBL] [Abstract][Full Text] [Related]
8. S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.
Huang Y; Hu K; Zhang S; Dong X; Yin Z; Meng R; Zhao Y; Dai X; Zhang T; Yang K; Liu L; Huang K; Shi S; Zhang Y; Chen J; Wu G; Xu S
Theranostics; 2018; 8(5):1286-1300. PubMed ID: 29507620
[No Abstract] [Full Text] [Related]
9. Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma.
Kong LR; Tan TZ; Ong WR; Bi C; Huynh H; Lee SC; Chng WJ; Eichhorn PJA; Goh BC
Mol Oncol; 2017 Aug; 11(8):965-980. PubMed ID: 28397399
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC.
Lankes K; Hassan Z; Doffo MJ; Schneeweis C; Lier S; Öllinger R; Rad R; Krämer OH; Keller U; Saur D; Reichert M; Schneider G; Wirth M
Mol Oncol; 2020 Dec; 14(12):3048-3064. PubMed ID: 33099868
[TBL] [Abstract][Full Text] [Related]
12. Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia.
Huang H; Weng H; Dong B; Zhao P; Zhou H; Qu L
Sci Rep; 2017 Jan; 7():41525. PubMed ID: 28128329
[TBL] [Abstract][Full Text] [Related]
13. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
14. Novel ubiquitin-independent nucleolar c-Myc degradation pathway mediated by antizyme 2.
Murai N; Murakami Y; Tajima A; Matsufuji S
Sci Rep; 2018 Feb; 8(1):3005. PubMed ID: 29445227
[TBL] [Abstract][Full Text] [Related]
15. Degrasyn activates proteasomal-dependent degradation of c-Myc.
Bartholomeusz G; Talpaz M; Bornmann W; Kong LY; Donato NJ
Cancer Res; 2007 Apr; 67(8):3912-8. PubMed ID: 17440106
[TBL] [Abstract][Full Text] [Related]
16. A natural small molecule, catechol, induces c-Myc degradation by directly targeting ERK2 in lung cancer.
Lim do Y; Shin SH; Lee MH; Malakhova M; Kurinov I; Wu Q; Xu J; Jiang Y; Dong Z; Liu K; Lee KY; Bae KB; Choi BY; Deng Y; Bode A; Dong Z
Oncotarget; 2016 Jun; 7(23):35001-14. PubMed ID: 27167001
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity.
Li H; Fang Y; Niu C; Cao H; Mi T; Zhu H; Yuan J; Zhu J
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9317-E9324. PubMed ID: 30181285
[TBL] [Abstract][Full Text] [Related]
18. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer.
Hidayat M; Mitsuishi Y; Takahashi F; Tajima K; Yae T; Miyahara K; Hayakawa D; Winardi W; Ihara H; Koinuma Y; Wirawan A; Nurwidya F; Kato M; Kobayashi I; Sasaki S; Takamochi K; Hayashi T; Suehara Y; Moriyama M; Moriyama H; Habu S; Takahashi K
Bosn J Basic Med Sci; 2019 Nov; 19(4):355-367. PubMed ID: 31202256
[TBL] [Abstract][Full Text] [Related]
19. Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.
Luanpitpong S; Angsutararux P; Samart P; Chanthra N; Chanvorachote P; Issaragrisil S
Sci Rep; 2017 Sep; 7(1):10607. PubMed ID: 28878262
[TBL] [Abstract][Full Text] [Related]
20. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.
Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J
Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
